ZIM Laboratories Limited (BOM:541400)

ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	225.95	251.22	19.47	96	64.21	34.2
Short-Term Investments	-	151.3	0.9	2.84	-	-
Cash & Short-Term Investments	225.95	402.52	20.37	98.84	64.21	34.2
Cash Growth	388.02%	1876.42%	-79.40%	53.95%	87.72%	145.62%
Accounts Receivable	1,014	1,090	1,069	1,035	987.12	977.47
Other Receivables	-	0.71	0.76	0.34	0.28	0.39
Receivables	1,014	1,091	1,070	1,035	987.4	978.08
Inventory	851.87	937.75	864.7	812.63	537.06	752.84
Prepaid Expenses	-	29	24.01	18.3	17.55	9.81
Other Current Assets	404.98	297.72	334.04	311.49	303.27	346.43
Total Current Assets	2,497	2,758	2,313	2,276	1,909	2,121
Property, Plant & Equipment	2,329	2,152	2,024	1,804	1,216	1,069
Long-Term Investments	0.5	0.5	0.5	0.52	0.52	0.52
Goodwill	1.69	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	480.41	419.49	321.74	224.9	139.21	103.49
Long-Term Deferred Tax Assets	5.08	4.6	2.51	-	-	-
Other Long-Term Assets	164.69	57.58	59.25	160.13	149.3	120.57
Total Assets	5,478	5,394	4,723	4,468	3,416	3,416

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	650.71	729.29	695.06	623.81	582.39	810.71
Accrued Expenses	-	102.93	101.38	78.83	83.93	51.18
Short-Term Debt	-	621.3	524.61	550.4	228.8	173.45
Current Portion of Long-Term Debt	833.61	192.66	194.04	157.12	120.63	150.4
Current Portion of Leases	22.84	27.43	35.64	24.72	15.72	14.07
Current Income Taxes Payable	17.73	25.76	29.2	-	-	20.66
Current Unearned Revenue	-	-	-	4.88	3.66	4.48
Other Current Liabilities	293.02	204.56	83.72	154.5	72.74	234.17
Total Current Liabilities	1,818	1,904	1,664	1,594	1,108	1,459
Long-Term Debt	627.94	415.88	403.01	356.01	246.25	189.23
Long-Term Leases	26.75	8.32	20.7	29.5	10.18	7.22
Long-Term Deferred Tax Liabilities	81.78	104.2	113.01	101.01	48.03	3.63
Total Liabilities	2,554	2,432	2,200	2,081	1,412	1,659

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	536.59	535	487.26	487.26	487.26	162.42
Additional Paid-In Capital	-	381.46	80.3	80.3	80.3	409.89
Retained Earnings	-	1,759	1,701	1,585	1,416	1,177
Comprehensive Income & Other	2,387	286.47	253.62	234.97	19.61	8.23
Total Common Equity	2,924	2,962	2,522	2,387	2,003	1,757
Minority Interest	0	0.01	0.01	0	-	-
Shareholders' Equity	2,924	2,962	2,522	2,387	2,003	1,757
Total Liabilities & Equity	5,478	5,394	4,723	4,468	3,416	3,416

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,511	1,266	1,178	1,118	621.58	534.37
Net Cash (Debt)	-1,285	-863.07	-1,158	-1,019	-557.38	-500.17
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-25.02	-17.62	-23.76	-20.91	-11.44	-10.26
Filing Date Shares Outstanding	53.93	53.5	48.73	48.73	48.73	48.73
Total Common Shares Outstanding	53.93	53.5	48.73	48.73	48.73	48.73
Working Capital	679.34	854.16	649.43	682.23	801.61	662.27
Book Value Per Share	54.22	55.36	51.77	49.00	41.12	36.06
Tangible Book Value	2,442	2,540	2,199	2,161	1,863	1,652
Tangible Book Value Per Share	45.28	47.48	45.13	44.35	38.23	33.90
Land	-	96.16	96.16	96.16	96.16	96.16
Buildings	-	845.19	819.87	790.03	503.21	471.4
Machinery	-	1,433	1,364	1,338	1,018	943.73
Construction In Progress	-	587.6	440.54	235.16	178.39	50.97

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error